Health and Healthcare
5864 Articles
Beigene has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Valeant Pharmaceuticals reported its third-quarter financial results before the markets opened on Monday.
Over the past week, a few biotech companies, such as Cepheid and Valeant Pharmaceuticals, made absolutely massive runs.
PTC Therapeutics traded higher Friday morning following the release of an incredibly positive analyst report.
Cempra made waves in the market on Friday morning on Phase 3 trial news. Despite announcing positive top-line results, shares…
These three top biotech names are very good bets for investors looking to add high-quality companies with less volatility and…
ThinkstockIn the world investing, a fire or problem at one company often means that its peers and rivals are likely…
Appellis Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering.
ThinkstockUnitedHealth Group Inc. (NYSE: UNH) released its third-quarter financial results before the markets opened on Thursday. The health insurance giant…
Tetraphase Pharmaceuticals continues to reel from the spectacular and unexpected failure of its flagship candidate, eravacycline.
UnitedHealth Group is scheduled to report its third-quarter financial results Thursday before the markets open.
Axsome Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Can-Fite BioPharma announced that it has entered into definitive agreements with existing institutional investors in regard to a secondary offering.
Nabriva Therapeutics entered the market in mid-September, and now the quiet period has passed, allowing the underwriters can make calls.
Dimension Therapeutics expects to offer 5.5 million shares within the price range of $14 to $16 in an IPO valued…
Our top personal finance-related articles today. Your wallet will thank you later.